Intranasal delivery bypasses the blood-brain barrier to target therapeutics to the brain to improve memory in humans with Alzheimer's disease and treat neurological and psychiatric disorders in animal models uri icon
Overview
publication date
  • 2007
  • Research
    keywords
  • Alzheimer's Disease
  • Animal
  • Drugs
  • Intranasal Administration
  • Models
  • Therapy